Pharmaceutical

Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement

CHICAGO, IL / ACCESSWIRE / July 20, 2023 / Cosmos Health Inc. (the "Company") (NASDAQ:COSM), a global healthcare group with…

12 months ago

Chiesi USA CEO Appointed to ASHP Foundation Board of Directors

CEO Jon Zwinski to serve a two-year term on the Board of Directors starting in June 2023, deepening the partnership…

12 months ago

Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023

New data demonstrates that ART26.12 works by activating multiple receptors implicated in pain signaling and is able to broadly modify…

12 months ago

Abeona Therapeutics Joins Rare Disease Company Coalition

CLEVELAND, July 19, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare…

12 months ago

Zymeworks To Host Second Quarter 2023 Results Conference Call

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional…

12 months ago

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023SCOTTSDALE,…

12 months ago

Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023

– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023…

12 months ago

Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are…

12 months ago

First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering

BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),…

12 months ago

Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer

NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing…

12 months ago